Coya’s biologic therapeutic aims to suppress chronic inflammation by targeting two key immune pathways simultaneously. A new paper published in … Continue reading "Combination therapy demonstrates ‘synergistic anti-inflammatory effects’" The...
Startup aims for clinical trials of microglia-targeting FTD treatment that âreprogramsâ the brainâs immune system into a protective state. Neuro-focused … Continue reading "Modulo Bio lands $4.8m ADDF investment to...
Epigenetic reprogramming startup identifies multiple sets of transcription factors with potential in liver disease and immune dysfunction. As Life Biosciences … Continue reading "NewLimit restores âyouthful functionâ to liver and...
